Asgard Therapeutics
Operator of a pioneering private biotech company intended for in vivo direct cell reprogramming for cancer immunotherapy. The company builds reprogramming technologies to develop gene therapy products...
Valuation
$0
Share Price
N/A
Total Raised
$82.6M
Last Round
N/A